啟迪國際(00872.HK)預計年度虧損2.5億至3億港元
格隆匯2月1日丨啟迪國際(00872.HK)發佈公吿,在計及可能就落實集團截至2020年12月31日止年度的年度業績作出的任何調整(包括但不限於減值虧損、撥備等)前,預期期間集團將錄得虧損淨額約港幣2.5億元至港幣3億元(2019年同期:虧損淨額港幣3.01億元)。
本期間虧損淨額主要歸因於與2019年同期相比,本期間的無形資產攤銷增加至約港幣6000萬元及有關借款利息及其他相關融資成本的融資成本增加至約港幣1億元,儘管與2019年同期相比,於本期間就出售一間附屬公司確認一次性收益約港幣5000萬元、持續經營業務收益温和增加至約港幣7.2億元及毛利增加至約港幣9000萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.